Distance from the anal verge as an indirect measure to predict response to anti-EGFR therapy in left side metastatic colon cancer

Autor:	Renata Arakelian, Fernando Picon, Raphael L. C. Araujo, Paula Freire Cardoso, Raphael Brandao Moreira, Mariana Ribeiro Monteiro, Jessica Sayuri Tsukamoto, Daniela Pezzutti Domingues Armentano
Rok vydání:	2019
Předmět:	Oncology Cancer Research medicine.medical_specialty Response to therapy business.industry Internal medicine Anal verge Medicine business Left sided Metastatic colon cancer
Zdroj:	Journal of Clinical Oncology. 37:e15153-e15153
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2019.37.15_suppl.e15153
Popis:	e15153 Background: Right and left sided colon cancers (RC, LC) differ with respect to biology and response to therapy. Several retrospective analyses have assessed the clinical effect of epidermal growth fator receptor (EGFR) targeted agents in patients with metastatic CRC (mCRC) according to the primary tumor location. Differentiating only right from left. But can in the LC responses differ according to the distance from the anal verge (DAV)? Methods: Exploratory retrospective analyses was planned to evaluate if LC responses differ according to the DAV. LC was defined as tumors originating anywhere from the distal rectum to the left colic flexure (splenic flexure). DAV was describe in cm measured by previous to surgery or treatment, colonoscopy, CT or MRI. Patients were divided for analysis purposes in two groups: Group A (tumors above 12cm from de anal verge), Group B (tumors below 12cm from the anal verge). Results: We retrospectively evaluated 29 patients with left metastatic colorectal cancer treated with anti-EGFR therapy as part of their treatment at the Paulistano Hospital -São Paulo from 2011 to 2018. Median population age 51.8 years (48.5-62.3). Median DAV 14.5 (4.6-25 cm). Median follow-up 12.8 months. No significant difference on stable and partial response rate was detected (Group A 43.7% vs Gropup B 56.3%), p=0.211. Long-rank test with a median pFS 8,5 meses and a PFS at 6 months of 66.7 vs 78,8 (Group A and Group B respectively ), p=0.901. Two-year OS was 58.4 % in Group A and 100% in Group B, p=0.17. Conclusions: Although no significant diferences were detected, responses rates were numerically higher in patients with tumors located below 12 cm from the anal verge. Further studies are needed to evaluate the association between response and DAV.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::13a47800923d66a67ef50ea4d191a720 https://doi.org/10.1200/jco.2019.37.15_suppl.e15153 Zobrazit plný text záznamu